Abstract
Like many therapies, the treatment of prostate cancer has evolved over the years. While the radical prostatectomy began as the initial curative treatment, it was associated with significant co-morbidities that greatly affected a patient’s quality of life. The improvement in surgical technique and improved description of the anatomy has led to significant improvements in the outcomes. Advances in irradiation techniques have also added to the options a patient has to consider when deciding on a treatment for his prostate cancer. Treatments have continued to improve to become less invasive and less impactful on a patient’s quality of life. However, to date, the options all have very similar outcomes in regard to cancer control, potency and urinary control, which have been described as the “trifecta” goal of prostate cancer treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Young HH (1905) The early diagnosis and radical cure of carcinoma of the prostate. Johns Hopkins Hosp Bull 16:315–321
Millin T (1945) Retropubic prostatectomy; a new extravesical technique; report of 20 cases. Lancet 2:693–696
Walsh PC, Donker PJ (1982) Impotence following radical prostatectomy: insight into etiology and prevention. J Urol 128:492–497
Walsh PC (2007) The discovery of the cavernous nerves and development of nerve sparing radical retropubic prostatectomy. J Urol 177:1632–1635
Kundu SD, Roehl KA, Eggener SE et al (2004) Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 172:2227–2231
Pasteau O, Degrais P (1914) The radium treatment of cancer of the prostate. Arch Roentgen Ray 18:396
Sklar GN, Eddy HA, Jacobs SC et al (1993) Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis. J Urol 150:1526–1532
Sogani PC, Whitmore WF Jr, Hilaris BS et al (1980) Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma. Scand J Urol Nephrol Suppl 55:205–211
Blasko JC, Ragde H, Grimm PD (1991) Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand J Urol Nephrol Suppl 137:113–118
Schuessler WW, Kavoussi L, Clayman RV (1992) Laparoscopic radical prostatectomy: initial case report [abstr 130]. J Urol Suppl 147:246A
Schuessler WW, Schulam PG, Clayman RV et al (1997) Laparoscopic radical prostatectomy: initial short-term experience. Urology 50:854–857
Abbou CC, Salomon L, Hoznek A et al (2000) Laparoscopic radical prostatectomy: preliminary results. Urology 55:630–634
Guillonneau B, Cathelineau X, Barret E et al (1999) Laparoscopic radical prostatectomy: technical and early oncological assessment of 40 operations. Eur Urol 36:14–20
Rassweiler J, Sentker L, Seemann O et al (2001) Heilbronn laparoscopic radical prostatectomy. Technique and results after 100 cases. Eur Urol 40:54–64
Bollens R, Van den Bossche M, Roumeguere T et al (2001) Extraperitoneal laparoscopic radical prostatectomy. Results after 50 cases. Eur Urol 40:65–69
Trabulsi EJ, Guillonneau B (2005) Laparoscopic radical prostatectomy. J Urol 173:1072–1079
Menon M, Shrivastava A, Tewari A et al (2002) Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol 168:945–949
Ahlering TE, Skarecky D, Lee D et al (2003) Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: initial experience with laparoscopic radical prostatectomy. J Urol 170:1738–1741
Guillonneau B (2003) What robotics in urology? A current point of view. Eur Urol 43:103–105
Cooper IS, Lee AS (1961) Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biologic tissues. J Nerv Ment Dis 133:259–263
Baust JG, Gage AA (2005) The molecular basis of cryosurgery. BJU Int 95:1187–1191
Gage AA, Baust J (1998) Mechanisms of tissue injury in cryosurgery. Cryobiology 37:171–186
Hoffmann NE, Bischof JC (2002) The cryobiology of cryosurgical injury. Urology 60:40–49
Onik GM, Cohen JK, Reyes GD et al (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72:1291–1299
Saliken JC, Donnelly BJ, Rewcastle JC (2002) The evolution and state of modern technology for prostate cryosurgery. Urology 60:26–33
Bahn DK, Lee F, Badalament R et al (2002) Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60:3–11
Donnelly BJ, Saliken JC, Ernst DS et al (2002) Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 60:645–649
Ellis DS (2002) Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology 60:34–39
Han KR, Cohen JK, Miller RJ et al (2003) Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170:1126–1130
Shinohara K (2003) Prostate cancer: cryotherapy. Urol Clin North Am 30:725–736, viii
Robinson JW, Donnelly BJ, Saliken JC et al (2002) Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 60:12–18
Madersbacher S, Pedevilla M, Vingers L et al (1995) Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55:3346–3351
Chapelon JY, Ribault M, Vernier F et al (1999) Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. Eur J Ultrasound 9:31–38
Thuroff S, Chaussy C, Vallancien G et al (2003) High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17:673–677
Uchida T, Nitta M, Hongo S et al (2007) High-intensity focused ultrasound for the treatment in 503 patients with localized prostate cancer. Urology 70:2
Bentzen SM, Ritter MA (2005) The alpha/beta ratio for prostate cancer: what is it, really? Radiother Oncol 76:1–3
King CR, Fowler JF (2001) A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys 51:213–214
King CR, Lehmann J, Adler JR et al (2003) CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Technol Cancer Res Treat 2:25–30
Madsen BL, Hsi RA, Pham HT et al (2007) Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 67:1099–1105
Freeman DE, King CR (2011) Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiat Oncol 6:3
King CR, Brooks JD, Gill H et al (2011) Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer. Int J Radiat Oncol Biol Phys 2011 Feb. 5 (Epub Ahead of print)
Allaf ME, Carter H (2005) The results of watchful waiting for prostate cancer. AUA Update Series 24:1–7
Fowler FJ Jr, McNaughton Collins M, Albertsen PC et al (2000) Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283:3217–3222
Carter HB, Walsh PC, Landis P et al (2002) Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. J Urol 167:1231–1234
Johansson JE (1994) Expectant management of early stage prostatic cancer: Swedish experience. J Urol 152:1753–1756
Klotz L (2005) Active surveillance for prostate cancer: for whom? J Clin Oncol 23:8165–8169
Choo R, Klotz L, Danjoux C et al (2002) Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167:1664–1669
Lu-Yao GL, Yao SL (1997) Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 349:906–910
Bill-Axelson A, Holmberg L, Ruutu M et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977–1984
Warlick C, Trock BJ, Landis P et al (2006) Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst 98:355–357
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ponsky, L.E., Vricella, G. (2012). Prostate Surgery and the Evolution to Minimally Invasive Therapies. In: Ponsky, L., Fuller, D., Meier, R., Ma, C. (eds) Robotic Radiosurgery. Treating Prostate Cancer and Related Genitourinary Applications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11495-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-11495-3_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11494-6
Online ISBN: 978-3-642-11495-3
eBook Packages: MedicineMedicine (R0)